PRKN and cancer: The above results suggest that metformin synergizes arsenic trioxide to trigger Parkin/pink1-dependent mitophagic cell death in HeLa cells, which show not only theoretical significance of exploring anti-cancer mechanisms of metformin but also the potential application of combination of metformin and arsenic trioxide in treatment of cervical cancer.